Arteriopatia perifèrica (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Arteriopatia perifèrica" in Catalan language version.

refsWebsite

Global rank Catalan rank

24nih.gov

4^th place

7^th place

12doi.org

2^nd place

6^th place

2web.archive.org

1^st place

2onlinejacc.org

low place

1merck.com

6,464^th place

6,588^th place

1stanford.edu

179^th place

194^th place

1guideline.gov

low place

1thelancet.com

2,393^rd place

2,029^th place

1oxfordjournals.org

1,389^th place

367^th place

1worldwidewounds.com

low place

1ama-assn.org

3,257^th place

2,661^st place

ama-assn.org

jama.ama-assn.org

Berger JS, Mori JK, John MK, William RH «Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease: A Meta-analysis of Randomized Trials». JAMA, 301, 18, 2009, pàg. 1909-1919. DOI: 10.1001/jama.2009.623 [Consulta: 17 gener 2023].

doi.org

dx.doi.org

Polonsky TS1, Taillon LA, Sheth H, Min JK, Archer SL, Ward RP «The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing». Atherosclerosis, 207, 2, Dec 2009, pàg. 440-4. DOI: 10.1016/j.atherosclerosis.2009.05.005.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». Eur J Vasc Endovasc Surg., 33, Suppl 1, 2007, pàg. S1–75. Arxivat de l'original el 2013-11-26. DOI: 10.1016/j.ejvs.2006.09.024. PMID: 17140820 [Consulta: 20 febrer 2014]. Arxivat 2013-11-26 a Wayback Machine.
Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ «Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men». JAMA, 308(16), Oct 2012, pàg. 1660-7. DOI: 10.1001/jama.2012.13415.
Hirsch AT; Bakal, Curtis W.; Creager, Mark A.; Halperin, Jonathan L.; Hiratzka, Loren F.; Murphy, William R.C.; Olin, Jeffrey W.; Haskal ZJ; Hertzer NR; 3 «ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation». J. Am. Coll. Cardiol., 47, 6, 2006, pàg. 1239–312. Arxivat de l'original el 2009-01-11. DOI: 10.1016/j.jacc.2005.10.009. PMID: 16545667 [Consulta: 13 febrer 2014]. Arxivat 2009-01-11 a Wayback Machine.
Ferket BS1, Spronk S, Colkesen EB, Hunink MG «Systematic review of guidelines on peripheral artery disease screening». Am J Med, 125, 2, Feb 2012, pàg. 198-208. DOI: 10.1016/j.amjmed.2011.06.027.
Jennifer S. Lin, MD, MCR; Carin M. Olson, MD, MS; Eric S. Johnson, PhD; and Evelyn P. Whitlock, MD, MPH «The Ankle–Brachial Index for Peripheral Artery Disease Screening and Cardiovascular Disease Prediction Among Asymptomatic Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force». Ann Intern Med, 159, 5, 2013, pàg. 333-341. DOI: doi:10.7326/0003-4819-159-5-201309030-00007.
Burns P, Gough S, Bradbury AW; Gough; Bradbury «Management of peripheral arterial disease in primary care». BMJ, 326, 7389, 3-2003, pàg. 584–8. DOI: 10.1136/bmj.326.7389.584. PMC: 1125476. PMID: 12637405.
Robless P, Mikhailidis DP, Stansby GP «Cilostazol for peripheral arterial disease». Cochrane Database Syst Rev, 1, 2008, p. CD003748. DOI: 10.1002/14651858.CD003748.pub3.
Salhiyyah, Kareem; Senanayake, Eshan; Abdel-Hadi, Mohammed; Booth, Andrew. «Pentoxifylline for intermittent claudication». A: Cochrane Database of Systematic Reviews, 2012. DOI 10.1002/14651858.CD005262.pub2.
Berger JS, Mori JK, John MK, William RH «Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease: A Meta-analysis of Randomized Trials». JAMA, 301, 18, 2009, pàg. 1909-1919. DOI: 10.1001/jama.2009.623 [Consulta: 17 gener 2023].
Fowkes FG, Gillespie IN «Angioplasty (versus non surgical management) for intermittent claudication». Cochrane Database Syst Rev, 2, 2000, pàg. CD000017. DOI: 10.1002/14651858.CD000017. PMID: 10796469.
Twine CP, Coulston J, Shandall A, McLain AD «Angioplasty versus stenting for superficial femoral artery lesions». Cochrane Database Syst Rev, 2, 2009, pàg. CD006767. DOI: 10.1002/14651858.CD006767.pub2. PMID: 19370653.

guideline.gov

Hirsch AT; Bakal, Curtis W.; Creager, Mark A.; Halperin, Jonathan L.; Hiratzka, Loren F.; Murphy, William R.C.; Olin, Jeffrey W.; Haskal ZJ; Hertzer NR; 3 «ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation». J. Am. Coll. Cardiol., 47, 6, 2006, pàg. 1239–312. Arxivat de l'original el 2009-01-11. DOI: 10.1016/j.jacc.2005.10.009. PMID: 16545667 [Consulta: 13 febrer 2014]. Arxivat 2009-01-11 a Wayback Machine.

merck.com

Peripheral Arterial Disease at Merck Manual of Diagnosis and Therapy Professional Edition, Retrieved on August 9, 2010

nih.gov

ncbi.nlm.nih.gov

Fontaine R, Kim M, Kieny R «Die chirugische Behandlung der peripheren Durchblutungsstörungen. (Surgical treatment of peripheral circulation disorders)» (en alemany). Helvetica Chirurgica Acta, 21, 5/6, 1954, pàg. 499–533. PMID: 14366554.
Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN «Recommended standards for reports dealing with lower extremity ischemia: revised version». J Vasc Surg, 26(3), Sep 1997, pàg. 517-38.
Polonsky TS1, Taillon LA, Sheth H, Min JK, Archer SL, Ward RP «The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing». Atherosclerosis, 207, 2, Dec 2009, pàg. 440-4. DOI: 10.1016/j.atherosclerosis.2009.05.005.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». Eur J Vasc Endovasc Surg., 33, Suppl 1, 2007, pàg. S1–75. Arxivat de l'original el 2013-11-26. DOI: 10.1016/j.ejvs.2006.09.024. PMID: 17140820 [Consulta: 20 febrer 2014]. Arxivat 2013-11-26 a Wayback Machine.
Bhatt DL1, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PW; REACH Registry Investigators «International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis». JAMA, 295, 2, 2006, pàg. 180-9.
Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ «Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men». JAMA, 308(16), Oct 2012, pàg. 1660-7. DOI: 10.1001/jama.2012.13415.
Price J, Mowbray P, Lee A, Rumley A, Lowe G, Fowkes F «Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease; Edinburgh Artery Study Edinburgh Artery Study». European heart journal, 20(5), 1999, pàg. 344-353.
Smith GD, Shipley M, Rose G «Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study.». Circulation, 82(6), 1990, pàg. 1925-1931.
Cole C, Hill G, Farzad E, Bouchard A, Moher D, Rody K, Shea B «Cigarette smoking and peripheral arterial occlusive disease». Surgery, 114(4), 1993, pàg. 753.
Hirsch AT; Bakal, Curtis W.; Creager, Mark A.; Halperin, Jonathan L.; Hiratzka, Loren F.; Murphy, William R.C.; Olin, Jeffrey W.; Haskal ZJ; Hertzer NR; 3 «ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation». J. Am. Coll. Cardiol., 47, 6, 2006, pàg. 1239–312. Arxivat de l'original el 2009-01-11. DOI: 10.1016/j.jacc.2005.10.009. PMID: 16545667 [Consulta: 13 febrer 2014]. Arxivat 2009-01-11 a Wayback Machine.
Kannel WB, McGee D «Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study». Diabetes care, 2(2), 1979, pàg. 120-126.
Creager MA, Lüscher TF, Cosentino F, Beckman JA «Diabetes and vascular disease pathophysiology, clinical consequences, and medical therapy: part I». Circulation, 108(12), 2003, pàg. 1527-1532.
Lüscher TF, Creager MA, Beckman JA, Cosentino F «Diabetes and vascular disease pathophysiology, clinical consequences, and medical therapy: Part II». Circulation, 108(13), 2003, pàg. 1655-1661.
Beks P, Mackaay A, De Neeling J, De Vries H, Bouter L, Heine R «Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study». Diabetologia, 38(1), 1995, pàg. 86-96.
Kannel W, McGee D «Update on some epidemiologic features of intermittent claudication: the Framingham Study». Journal of the American Geriatrics Society, 33(1), 1985, pàg. 13.
Selvin E, Erlinger TP «Prevalence of and risk factors for peripheral arterial disease in the united states results from the national health and nutrition examination survey, 1999–2000». Circulation, 110(6), 2004, pàg. 738-743.
Valentine RJ, Guerra R, Stephan P, Scoggins E, Clagett GP, Cohen J «Family history is a major determinant of subclinical peripheral arterial disease in young adults». Journal of vascular surgery, 39(2), 2004, pàg. 351-356.
Ridker PM, Stampfer MJ, Rifai N «Novel risk factors for systemic atherosclerosis». JAMA, 285(19), 2001, pàg. 2481-2485.
Leiner T, Kessels AG, Nelemans PJ, Vasbinder GB, de Haan MW, Kitslaar PE, Ho KY, Tordoir JH, van Engelshoven JM699-708 «Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis». Radiology, 235, 2, 2005 May, pàg. 699-708.
Leiner, T «Magnetic resonance angiography of abdominal and lower extremity vasculature». Top Magn Reson Imaging, 16, 1, 2005 Feb, pàg. 21-66.
Ferket BS1, Spronk S, Colkesen EB, Hunink MG «Systematic review of guidelines on peripheral artery disease screening». Am J Med, 125, 2, Feb 2012, pàg. 198-208. DOI: 10.1016/j.amjmed.2011.06.027.
Burns P, Gough S, Bradbury AW; Gough; Bradbury «Management of peripheral arterial disease in primary care». BMJ, 326, 7389, 3-2003, pàg. 584–8. DOI: 10.1136/bmj.326.7389.584. PMC: 1125476. PMID: 12637405.
Fowkes FG, Gillespie IN «Angioplasty (versus non surgical management) for intermittent claudication». Cochrane Database Syst Rev, 2, 2000, pàg. CD000017. DOI: 10.1002/14651858.CD000017. PMID: 10796469.
Twine CP, Coulston J, Shandall A, McLain AD «Angioplasty versus stenting for superficial femoral artery lesions». Cochrane Database Syst Rev, 2, 2009, pàg. CD006767. DOI: 10.1002/14651858.CD006767.pub2. PMID: 19370653.

onlinejacc.org

content.onlinejacc.org

Allison MA, Denenberg JO, Criqui MH «Family History of Peripheral Artery Disease Is Associated With Prevalence and Severity of Peripheral Artery Disease». Journal of the American College of Cardiology, 58(13), 2011.
Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, Golzarian J, Gornik HL, Halperin JL, Jaff MR «2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) a report of the American college of cardiology foundation/American heart association task force on practice guidelines». Journal of the American College of Cardiology, 58, 19, 2011, pàg. 2020-2045.

oxfordjournals.org

aje.oxfordjournals.org

Hooi JD, Kester AD, Stoffers HE, Overdijk MM, van Ree JW, Knottnerus JA «Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study». American journal of epidemiology, 153(7), 2001, pàg. 666-672.

stanford.edu

vascular.stanford.edu

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». Eur J Vasc Endovasc Surg., 33, Suppl 1, 2007, pàg. S1–75. Arxivat de l'original el 2013-11-26. DOI: 10.1016/j.ejvs.2006.09.024. PMID: 17140820 [Consulta: 20 febrer 2014]. Arxivat 2013-11-26 a Wayback Machine.

thelancet.com

Cholesterol Treatment Trialists «Unit ES: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins». Lancet, 366, 2005, pàg. 1267-1278.

web.archive.org

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group «Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)». Eur J Vasc Endovasc Surg., 33, Suppl 1, 2007, pàg. S1–75. Arxivat de l'original el 2013-11-26. DOI: 10.1016/j.ejvs.2006.09.024. PMID: 17140820 [Consulta: 20 febrer 2014]. Arxivat 2013-11-26 a Wayback Machine.
Hirsch AT; Bakal, Curtis W.; Creager, Mark A.; Halperin, Jonathan L.; Hiratzka, Loren F.; Murphy, William R.C.; Olin, Jeffrey W.; Haskal ZJ; Hertzer NR; 3 «ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation». J. Am. Coll. Cardiol., 47, 6, 2006, pàg. 1239–312. Arxivat de l'original el 2009-01-11. DOI: 10.1016/j.jacc.2005.10.009. PMID: 16545667 [Consulta: 13 febrer 2014]. Arxivat 2009-01-11 a Wayback Machine.

worldwidewounds.com

Vowden P, Vowden K «Doppler assessment and ABPI: Interpretation in the management of leg ulceration». Worldwide Wounds, 3-2001. - describes ABPI procedure, interpretation of results, and notes the somewhat arbitrary selection of "ABPI of 0.8 has become the accepted endpoint for high compression therapy, the trigger for referral for a vascular surgical opinion and the defining upper marker for an ulcer of mixed aetiology"